In ₹ Crore except Per Share Latest Annual	STAR FY26	SPARC FY26	SUPRIYA FY25	SHILPAMED FY26	Peer Average
Valuation — at last close
P/E	18.19×	◆ 3.82×	—	75.21×	39.52× -54%
P/B	◆ 3.26×	4.43×	—	7.06×	5.75× -43%
EV/EBITDA	12.55×	◆ 4.06×	—	43.51×	23.78× -47%
Market Cap	₹10,116 Cr	₹5,938 Cr	—	₹18,300 Cr	₹12,119 Cr -17%
Growth
Revenue CAGR 3Y	9.62%	◆ 95.98%	—	13.59%	54.79% -82%
Revenue CAGR 5Y	7.94%	—	—	◆ 11.30%	11.30% -30%
Revenue YoY (latest Q)	17.11%	◆ 314.11%	—	44.90%	179.50% -90%
Net Income YoY (latest Q)	1.97%	59.94%	—	◆ 115.16%	87.55% -98%
Profitability
EBITDA Margin	19.04%	◆ 85.08%	—	28.25%	56.66% -66%
Net Income Margin	11.82%	◆ 82.65%	—	15.81%	49.23% -76%
Return on Common Equity	19.66%	◆ 277.35%	—	9.80%	143.58% -86%
Return on Capital Employed	19.31%	◆ 230.55%	—	11.47%	121.01% -84%
Return on Assets	8.86%	◆ 123.94%	—	6.94%	65.44% -86%
Credit & Quality
Total Debt/Equity	0.53×	0.42×	◆ 0.00×	0.25×	0.22× +137%
Interest Coverage	4.05×	◆ 46.54×	—	5.36×	25.95× -84%
Scale — latest FY
Revenue / Total Income	₹4,859 Cr	₹1,879 Cr	—	₹1,539 Cr	₹1,709 Cr +184%
Net Income	₹575 Cr	₹1,553 Cr	—	₹243 Cr	₹898 Cr -36%
Total Assets	₹6,927 Cr	₹2,171 Cr	₹1,112 Cr	₹3,706 Cr	₹2,330 Cr +197%
EPS	₹60.34	₹47.86	—	₹12.44	₹30.15 +100%
Book Value per Share	₹337.14	₹41.26	—	₹132.47	₹86.87 +288%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.